Master data| INID | Criterion | Field | Content |
|---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
| 21 | DE file number | DAKZ | 603 51 497.9 |
| 96 | EP file number | EAKZ | 10 01 0453.8 |
| 97 | EP publication number | EPN | 2327421 |
| 54 | Designation/title | TI | Stabilisierte flüssige Anti-RSV-Antikörper-Formulierungen |
| 51 | IPC main class | ICM
(ICMV) | A61K 39/385 (2006.01) |
| 51 | IPC secondary class(es) | ICS
(ICSV) | A61K 39/42 (2006.01), C07K 16/00 (2006.01) |
| 22 | DE application date | DAT | Jun 16, 2003 |
| 96 | EP application date | EAT | Jun 16, 2003 |
| 43 | Date of first publication | OT | Jun 1, 2011 |
| Date of publication of grant | PET | Sep 19, 2018 |
| 71/73 | Applicant/owner | INH | MedImmune, LLC, Gaithersburg, Md., US |
| 72 | Inventor | IN | Oliver, Cynthia N., N Patomac, MD 20878, US; Shane, Erica, McLean, VA 22101, US; Issaacs, Benjamin S., Andover, MA 01810, US; Allan, Christian B., Brookville, MD 20833, US; Chang, Stephen, Frederick, MD 21701, US |
| Address for service | | RWS Group, Translation Division, CHALFONT ST PETER, Bucks SL9 9FG, GB |
33
31
32
| Foreign priority | PRC
PRNA
PRDA
| US
388921 P
Jun 14, 2002
|
| Patent division in charge | | 44 |
| 97 | EP language of publication | ELANG | EN - Englisch |
| 84 | Designated EP contracting states | EDS | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PT, RO, SE, SI, SK, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000002327421
Searchable text:
EP000002327421
Original document:
EP000002327421B1
Searchable text:
EP000002327421B1 |
| 43 | Date of first publication | EVT | Jun 1, 2011 |
| Date of the first transfer into DPMAregister | EREGT | Jul 14, 2011 |
| Date of the (most recent) update in DPMAregister | REGT | Jun 18, 2023
(Show all update days)(Hide all update days)- Jul 14, 2011
- Date of the first transfer into DPMAregister
|
